Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Endocrinology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location

Diabetes Mellitus, Type 2 Clinical Trials

A listing of Diabetes Mellitus, Type 2 medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (494) clinical trials

A Multicentre, International, Randomised, Parallel Group, Double Blind Study to Evaluate Cardiovascular Safety of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes Mellitus at High Cardiovascular Risk. Eligibility: Ages Eligible for Study: 40 Years to 85 Years Genders Eligible for Study: Both Accepts Healthy Volunteers: No Patient Inclusion Criteria: ...

Phase N/A

Winthrop University Hospital Clinical Trials Center is seeking volunteers who have been diagnosed with Type 2 Diabetes Mellitus, a condition that affects the patient’s blood glucose levels. This study is testing an investigational medication for diabetes to see if it is safe and effective. Eligible participants will receive study-related medications ...

Phase

Winthrop University Hospital Clinical Trials Center is conducting a clinical research study for participants (ages 10-17 years old), who have been diagnosed and have a history of type 2 diabetes. The purpose of this research study is to assess the safety and efficacy of a investigational non-insulin, injectable anti-diabetic medication ...

Phase

The purpose of this study is to evaluate the cardiovascular outcomes of alogliptin compared with placebo, in addition to standard of care, in patients with type II diabetes mellitus and acute coronary syndrome. Patient Inclusion Criteria: In order to participate in this study you need to have a hgA1c level ...

Phase

A multicenter, Randomized, Double-Blind, Placebo-controlled Study to determine the efficacy and safety of Alogliptin Plus Metformin, Alogliptin alone, or Metformin alone in subjects with Type 2 Diabetes Please contact us for eligibility criteria.

Phase N/A

A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapaglifozin in Subjects with Type 2 Diabetes with Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB). Please contact us for eligibility criteria.

Phase

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of xxxxxxxxx in Subjects with Type 2 Diabetes with Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB) Patient Inclusion Criteria: Subjects must be willing and able to give ...

Phase

Dr. Carlos Bernal-Mizrachi is conducting a study to determine whether vitamin D supplementation in diabetic African-Americans with low vitamin D levels will reduce the progression of vascular disease. This study will take about 13 months to complete. There will be about 8 outpatient study visits (about 1 – 3 hours ...

Phase

If you are a man or woman over the age of 18, you may be eligible to participate in a clinical research study evaluating the safety and effectiveness of an investigational form of insulin to reduce blood sugar levels in individuals with Type 2 Diabetes. There is no cost to ...

Phase N/A

Metabolic Research Institute may have a new path for you to take. To learn more about this study or to see if you qualify to participate, please call: 561-802-3060 You may qualify for an exciting clinical trial. www.metabolic-institute.com/information.htm.

Phase N/A